359 related articles for article (PubMed ID: 25981149)
1. HRS/NSA 2014 survey of atrial fibrillation and stroke: Gaps in knowledge and perspective, opportunities for improvement.
Frankel DS; Parker SE; Rosenfeld LE; Gorelick PB
Heart Rhythm; 2015 Aug; 12(8):e105-13. PubMed ID: 25981149
[TBL] [Abstract][Full Text] [Related]
2. HRS/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement.
Frankel DS; Parker SE; Rosenfeld LE; Gorelick PB
J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1691-700. PubMed ID: 26255580
[TBL] [Abstract][Full Text] [Related]
3. The Educational Needs of Clinicians Regarding Anticoagulation Therapy for Prevention of Thromboembolism and Stroke in Patients With Atrial Fibrillation.
Glauser TA; Barnes J; Nevins H; Cerenzia W
Am J Med Qual; 2016; 31(1):38-46. PubMed ID: 25115364
[TBL] [Abstract][Full Text] [Related]
4. Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
Lee VW; Tam CS; Yan BP; Man Yu C; Yin Lam Y
Clin Cardiol; 2013 Mar; 36(3):166-71. PubMed ID: 23151816
[TBL] [Abstract][Full Text] [Related]
5. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.
Potpara TS; Pison L; Larsen TB; Estner H; Madrid A; Blomström-Lundqvist C;
Europace; 2015 Mar; 17(3):468-72. PubMed ID: 25722478
[TBL] [Abstract][Full Text] [Related]
6. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Decisions in Atrial Fibrillation for Stroke Prevention: The Role of Aversion to Ambiguity and Physicians' Risk Preferences.
Sposato LA; Stirling D; Saposnik G
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2088-2095. PubMed ID: 29650382
[TBL] [Abstract][Full Text] [Related]
9. The Translation of Knowledge Into Practice in the Management of Atrial Fibrillation in Singapore.
Woo BFY; Lim TW; Tam WWS
Heart Lung Circ; 2019 Apr; 28(4):605-614. PubMed ID: 29705388
[TBL] [Abstract][Full Text] [Related]
10. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.
Hernández Madrid A; Potpara TS; Dagres N; Chen J; Larsen TB; Estner H; Todd D; Bongiorni MG; Sciaraffia E; Proclemer A; Cheggour S; Amara W; Blomstrom-Lundqvist C
Europace; 2016 Mar; 18(3):463-7. PubMed ID: 26899998
[TBL] [Abstract][Full Text] [Related]
11. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
Peterson GM; Boom K; Jackson SL; Vial JH
Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
[TBL] [Abstract][Full Text] [Related]
12. Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians.
Wong CX; Lee SW; Gan SW; Mahajan R; Rangnekar G; Pathak RK; Twomey D; Schultz C; Ganesan AN; Brooks AG; Roberts-Thomson KC; Brown A; Lau DH; Sanders P
Int J Cardiol; 2015 Jul; 191():20-4. PubMed ID: 25965590
[TBL] [Abstract][Full Text] [Related]
13. Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study.
Vanbeselaere V; Truyers C; Elli S; Buntinx F; De Witte H; Degryse J; Henrard S; Vaes B
BMC Cardiovasc Disord; 2016 Mar; 16():61. PubMed ID: 27021333
[TBL] [Abstract][Full Text] [Related]
14. Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation.
Hua H; Sur N; Lee L; Chaturvedi S
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105474. PubMed ID: 33242786
[TBL] [Abstract][Full Text] [Related]
15. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives.
Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
J Clin Nurs; 2017 Dec; 26(23-24):4325-4334. PubMed ID: 28178370
[TBL] [Abstract][Full Text] [Related]
16. SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.
Kapoor A; Amroze A; Vakil F; Crawford S; Der J; Mathew J; Alper E; Yogaratnam D; Javed S; Elhag R; Lin A; Narayanan S; Bartlett D; Nagy A; Shagoury BK; Fischer MA; Mazor KM; Saczynski JS; Ashburner JM; Lopes R; McManus DD
Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e005871. PubMed ID: 32063041
[TBL] [Abstract][Full Text] [Related]
17. Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude.
Bahri O; Roca F; Lechani T; Druesne L; Jouanny P; Serot JM; Boulanger E; Puisieux F; Chassagne P
J Am Geriatr Soc; 2015 Jan; 63(1):71-6. PubMed ID: 25597559
[TBL] [Abstract][Full Text] [Related]
18. Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: cross-sectional population database study.
Dreischulte T; Barnett K; Madhok V; Guthrie B
Eur J Gen Pract; 2014 Sep; 20(3):181-9. PubMed ID: 24351017
[TBL] [Abstract][Full Text] [Related]
19. Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.
Haeusler KG; Gerth A; Limbourg T; Tebbe U; Oeff M; Wegscheider K; Treszl A; Ravens U; Meinertz T; Kirchhof P; Breithardt G; Steinbeck G; Nabauer M;
BMC Neurol; 2015 Aug; 15():129. PubMed ID: 26242880
[TBL] [Abstract][Full Text] [Related]
20. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
